129 related articles for article (PubMed ID: 33757890)
1. Trends of Acute Ischemic Stroke Reperfusion Therapies from 2012 to 2016 in the United States.
Nagaraja N; Kubilis PS; Hoh BL; Wilson CA; Khanna AY; Kelly AG
World Neurosurg; 2021 Jun; 150():e621-e630. PubMed ID: 33757890
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Acute Ischemic Stroke Treatment from 2010 to 2020: An Evolving Landscape in Stroke Management Following Thrombectomy Trials.
Elbayomy A; Kim JJ; Ammanuel SG; Traverzo D; Battula S; Ahmed A
Neurol Clin Pract; 2024 Jun; 14(3):e200297. PubMed ID: 38720953
[TBL] [Abstract][Full Text] [Related]
3. Real-World Treatment Trends in Endovascular Stroke Therapy.
Saber H; Navi BB; Grotta JC; Kamel H; Bambhroliya A; Vahidy FS; Chen PR; Blackburn S; Savitz SI; McCullough L; Sheth SA
Stroke; 2019 Mar; 50(3):683-689. PubMed ID: 30726185
[TBL] [Abstract][Full Text] [Related]
4. Age differences in utilization and outcomes of tissue-plasminogen activator and mechanical thrombectomy in acute ischemic stroke.
Nagaraja N; Patel UK; Chaturvedi S
J Neurol Sci; 2021 Jan; 420():117262. PubMed ID: 33333325
[TBL] [Abstract][Full Text] [Related]
5. Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era.
Akbik F; Xu H; Xian Y; Shah S; Smith EE; Bhatt DL; Matsouaka RA; Fonarow GC; Schwamm LH
JAMA Neurol; 2020 Dec; 77(12):1486-1495. PubMed ID: 32955582
[TBL] [Abstract][Full Text] [Related]
6. Endovascular stroke treatment does not preclude high thrombolysis rates.
Feda S; Nikoubashman O; Schürmann K; Matz O; Tauber SC; Wiesmann M; Schulz JB; Reich A
Eur J Neurol; 2019 Mar; 26(3):428-e33. PubMed ID: 30317687
[TBL] [Abstract][Full Text] [Related]
7. Sex and racial disparity in utilization and outcomes of t-PA and thrombectomy in acute ischemic stroke.
Nagaraja N; Olasoji EB; Patel UK
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104954. PubMed ID: 32807414
[TBL] [Abstract][Full Text] [Related]
8. Relevance of standard intravenous thrombolysis in endovascular stroke therapy of a tertiary stroke center.
Heinrichs A; Nikoubashman O; Schürmann K; Tauber SC; Wiesmann M; Schulz JB; Reich A
Acta Neurol Belg; 2018 Mar; 118(1):105-111. PubMed ID: 29435828
[TBL] [Abstract][Full Text] [Related]
9. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.
Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R
Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701
[TBL] [Abstract][Full Text] [Related]
10. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
11. Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States.
Saber H; Khatibi K; Szeder V; Tateshima S; Colby GP; Nour M; Jahan R; Duckwiler G; Liebeskind DS; Saver JL
Stroke; 2020 Nov; 51(11):3241-3249. PubMed ID: 33081604
[TBL] [Abstract][Full Text] [Related]
12. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.
Nasr DM; Biller J; Rabinstein AA
Pediatr Neurol; 2014 Nov; 51(5):624-31. PubMed ID: 25194722
[TBL] [Abstract][Full Text] [Related]
13. National Trends in Utilization and Outcome of Endovascular Thrombectomy for Acute Ischemic Stroke in Elderly.
Mehta A; Fifi JT; Shoirah H; Singh IP; Shigematsu T; Kellner CP; De Leacy R; Mocco J; Majidi S
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105505. PubMed ID: 33271488
[TBL] [Abstract][Full Text] [Related]
14. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
[TBL] [Abstract][Full Text] [Related]
16. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
[TBL] [Abstract][Full Text] [Related]
17. Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.
Yang W; Zhang L; Yao Q; Chen W; Yang W; Zhang S; He L; Li H; Zhang Y
Medicine (Baltimore); 2020 May; 99(20):e20187. PubMed ID: 32443338
[TBL] [Abstract][Full Text] [Related]
18. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
19. Plasma let-7i and miR-15a expression are associated with the effect of recombinant tissue plasminogen activator treatment in acute ischemic stroke patients.
Xiang W; Tian C; Lin J; Wu X; Pang G; Zhou L; Pan S; Deng Z
Thromb Res; 2017 Oct; 158():121-125. PubMed ID: 28892656
[TBL] [Abstract][Full Text] [Related]
20. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
